ææ°ã® Eli Lilly and Co ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
8æ6æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.11%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
8æ6æ¥ã®Insmed Inc (INSM) å€åãã¯31.83%äžæïŒå€åãã®èåŸã«ããäºå®
8æ6æ¥ã®Mckesson Corp (MCK) å€åãã¯3.44%äžèœïŒå®å šãªåæ
8æ5æ¥ã®Mckesson Corp (MCK) çµå€ã¯5.08%äžæïŒå€åãã®èåŸã«ããèŠå
8æ5æ¥ã®Bristol-Myers Squibb Co (BMY) å€åãã¯3.10%äžèœïŒå®å šãªåæ
8æ5æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.96%äžèœïŒå®å šãªåæ
8æ5æ¥ã®Amgen Inc (AMGN) å€åãã¯4.57%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
8æ5æ¥ã®AstraZeneca PLC (AZN) å€åãã¯4.30%äžæïŒå€åãã®èåŸã«ããäºå®
8æ5æ¥ã®Eli Lilly and Co (LLY) å€åãã¯6.32%äžæïŒå®å šãªåæ
8æ4æ¥ã®Amgen Inc (AMGN) çµå€ã¯3.03%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±